Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2010082182) FULVIC ACID IN COMBINATION WITH FLUCONAZOLE OR AMPHOTERICIN B FOR THE TREATMENT OF FUNGAL INFECTIONS
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2010/082182 International Application No.: PCT/IB2010/050213
Publication Date: 22.07.2010 International Filing Date: 18.01.2010
IPC:
A61K 31/352 (2006.01) ,A61K 31/4196 (2006.01) ,A61K 31/7048 (2006.01) ,A61K 45/06 (2006.01) ,A61P 31/10 (2006.01)
[IPC code unknown for A61K 31/352][IPC code unknown for A61K 31/4196][IPC code unknown for A61K 31/7048][IPC code unknown for A61K 45/06][IPC code unknown for A61P 31/10]
Applicants:
WARN, Peter [GB/GB]; GB (UsOnly)
LEIVERS, Stephen William [GB/GB]; GB (UsOnly)
NATRACINE UK LIMITED [GB/GB]; Legh Coach House Wilmslow Road Mottram St Andrew Cheshire SK10 4QH, GB (AllExceptUS)
DONALD, Heather June [ZA/ZA]; ZA (IS)
Inventors:
WARN, Peter; GB
LEIVERS, Stephen William; GB
Agent:
SPOOR & FISHER; P O Box 454 0001 Pretoria, ZA
Priority Data:
0900786.519.01.2009GB
Title (EN) FULVIC ACID IN COMBINATION WITH FLUCONAZOLE OR AMPHOTERICIN B FOR THE TREATMENT OF FUNGAL INFECTIONS
(FR) ACIDE FULVIQUE ASSOCIÉ À DU FLUCONAZOLE OU DE L'AMPHOTÉRICINE B DANS LE TRAITEMENT D'INFECTIONS FONGIQUES
Abstract:
(EN) A combination of fulvic acid or a salt, ester, or derivative thereof and an antifungal compound selected from fluconazole and amphotericin B for use in the treatment or prophylaxis of a disease or condition of the human or animal body is described. The fulvic acid can be CHD-FA.
(FR) La présente invention concerne une combinaison d'acide fulvique ou de l'un de ses sels, esters ou dérivés ainsi que d'un composé antifongique choisi parmi le fluconazole et l'amphotéricine B pour application au traitement prophylactique ou thérapeutique d'une pathologie ou d'un état pathologique de l'organisme d'un homme ou d'un animal. L'acide fulvique peut être le CHD-FA.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)